Prioritis

Bronze Sponsor

Information

Through its Prismaccess and PrismHEOR online platforms, Prioritis delivers daily, intelligent and reliable published and upcoming data regarding pharmaceutical HTA and reimbursement decisions.                                                                                                Providing unmatched competencies in data collection and analysis - Offering the most valuable path to market access - Raising consistency and reducing uncertainty.

Social media

Contact details

contact@prioritis.com
https://www.prioritis.com/

Sessions

Roundtable: New HTA requirements in France: impact of unmet need on access

Thursday, September 24, 2020 10:00 AM to 10:45 AM
Roundtables 2

Documents & Links

Prioritis - the data expertise
AI to gain greater experience and understandingForecasts and screenings, accelerated search, real-time response, extraction and analysis, our data are processed with increasing power.
Economic evaluation landscape for oncology products (...)Economic evaluation landscape for oncology products with a focus on the key challenges across England, France and Canada
Assessing the Public Health Benefit of a medicine (...)Assessing the Public Health Benefit of a medicine : An analysis of the criteria appraised by the French HTA body
Comparative study of PFS as primary endpoint (...)Comparative study of PFS as primary endpoint in European HTA (France and Germany)

Log in